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1. Introduction 
Alamethicin is a cyclic octadecapeptide containing 
2-methylalanine (aminoisobutyric acid, Aib), an 
unusual component. All other constituent amino 
acids are in the Lform. It has the structure [I] : 
1 2 3 4 5 
Pro - Aib - Ala - Aib - Ala 
I Gin 18 
(y) - Glu - Aib - Aib - Val 
17 16 15 14 
Fig.1. Structure of alamethicin 
Recent spectrometric studies suggest a linear struc- 
ture for this molecule: The amino terminus at 
Pro-l is protected by an acetyl group and the 
a-carboxyl at Glu-17 by a phenylalaninol molecule 
[2,31. 
Alamethicin is synthesized at the end of the 
exponential growth phase of Trichoderma viride- 
cultures and was first detected in the nutrient 
broth of submerged cultures in 1967 [4] . Reusser 
showed that cycloheximid failed to inhibit the 
in vivo formation of alamethicin, and took this as 
a proof of non-ribosomal biosynthesis [ 51. We 
have recently shown that the in vitro synthesis of 
alamethicin is neither influenced by RNase nor 
puromycin and that the constituent amino acids 
are activated in the form of thioesters on the 
synthesizing enzyme [6]. 
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Fractionation of alamethicin synthetase from 
extracts of Trichoderma viride by gel filtration on 
Sephadex G200 was also described [6]. This 
present paper describes the further purification and 
separation of the synthetase into two fractions by 
chromatography on hydroxyapatite. The amino 
6 7 8 9 
- Gin - Aib - Val - Aib 
- Pro - Aib - Leu - Gly 
13 12 11 10 
acid dependent ATP-32 PPi exchange reaction and 
the actual synthesis of alamethicin were used as a 
measure of enzyme activity. 
2. Materials and methods 
2.1. Enzyme preparation and purification 
Cultivation of the organism, preparation of 
cell-free extracts and partial purification of the 
alamethicin synthesizing enzyme system by gel 
filtration on Sephadex G200 were carried out as 
described [6]. The active fractions of the gel 
filtration were pooled and applied to a hydroxy- 
apatite column (1.5 X 15 cm, Hypatite C, Clarkson 
Chemical Comp., Williamsport). The column was 
washed with 100 ml of buffer A, and then eluted 
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with 400 ml of a linear gradient from 10 mM to 
200 mM of phosphate buffer, pH 7.0,5 ml frac- 
tions being collected. Amino acid dependent ATP- 
32PP. exchanges were tested as described by 
Geverrs et al. [7]. Radioactivity was counted in 
toluene scintillation liquid containing 2.8 g/l PPO 
and 0.9 g/l POPOP in a Nuclear Chicago Mark II 
scintillation counter. The buffer (A) used was 
10 mM phosphate, pH 7.0, containing 10 mM 
Mg”, 0.5 mM EDTA, 5 mM 2-mercaptoethanol and 
10% sucrose. 
2.2. Aminoacyl-tRNA-synthetase identification 
The tests were carried out according to Void 
[8]. The soluble tRNA from E. coli (Boehringer, 
Mannheim) was used. The incubation mixture 
contained 100 1.11 of the enzyme solution and 
100 ~1 of a solution containing 300 pg tRNA plus 
50 pg bovine serum albumin, 0.2 I.tmol ATP, 
1 pmol Mg”, and 0.2 /Xi of a l4 C-labeled amino 
acid in buffer A. In the control experiments the 
tRNA was omitted. Incubation was carried out 
for 30 min at 37°C. The reaction was stopped by 
the addition of 2 ml of cold 5% trichloroacetic 
acid. After 30 min in the cold, the precipitate 
was collected on a glass fiber filter and washed 
with 150 ml of cold 5% TCA, and then 30 ml of 
ethanol-ether (1: 1). After drying at 50” C, radio- 
activity was counted under toluene scintillation 
liquid in the Nuclear Chicago liquid scintillation 
counter. 
2.3. In vitro synthesis of alamethicin 
The 250 ~1 of incubation mixture contained 
200 ~1 of enzyme solution and 50 ~1 of a solution 
of buffer A containing 2.5 pmol ATP, 2.5 pmol 
Mg*. 0.2 pmol of each of seven of the alamethicin 
constituent amino acids and 0.2 &i of the eighth 
l4 C-labelled amino acid. Incubation was carried 
out for 30 min at 37°C. The mixture was lyophiliz- 
ed and the residue extracted with 2 ml n-butanol- 
chloroform (4: 1). The solvent was removed by 
evaporation and the residue dissolved in 200 ~1 
of ethanol, then applied to silica gel thin-layer 
plates (Kieselgel F 1500, Schleicher & Schiill, 
Dassel), and chromatographed. 
Solvent 1: n-butanol-acetic acid-water 
(4: 1: 1); solvent 2: ethylacetate-pyridine-acetic 
acid-water (60:20:6: 11). The plate was first 
developed with solvent 1 and then, after drying, 
with solvent 2, into the same direction. Radio- 
activity was located with a Berthold scanner. 
Radioactive bands in the range of the R, value 
of authentic alamethicin were scraped off and 
extracted with ethanol. After removal of the 
solvent, the residue was hydrolyzed in 250 ~1 of 
6 N HCl (1 10°C 16 h). The HCl was evaporated, 
and the residue was dissolved in 100 ~1 of aqueous 
ethanol, chromatographed and autoradiographed 
as described above. 
3. Results and discussion 
Fig.2 shows the separation of alamethicin 
synthetase by gel filtration on Sephadex G200. 
The ATP-32 PPi exchange stimulated by Aib was 
used for the assay. The effect of each of the eight 
constituent amino acids of alamethicin as well as 
of some other amino acids on the ATP-32PPi 
exchange is shown in table 1. For comparison, the 
aminoacyl-tRNA activities with the various amino 
acids are shown in table 2. It is clear that some. 
2.0 
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Fig.2. Separation of the alamethicin synthesizing system by 
gel filtration on Sephadex G 200 and identification by 
ATP-“PPi exchange. The 55% (NH),SO, precipitate 
obtained from the extract of 20 g wet mycelium was taken 
up in 5 ml buffer A and put on a column (2.6 X 90 cm) 
equilibrated with the same buffer. Elution was carried out 
with buffer A. Four ml-fractions were collected. (. . .) 
Absorbance at 280 nm; (o -0) represents the ATP-‘*PPi 
exchange activity dependent on L-Aib, (w----- 0) the 
amino acid independent exchange activity. The assay was 
carried out according to Gevers et al. [7). 
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Table 1 
Ammo acid dependent ATP-“PPl exchange (cpm X 10W3) 
Amino acid Sephadex G 200 
peak fraction 
Hydroxyapatite 
peak 1 
fractionation 
peak 2 
Aib 12.0 4.1 0.18 
L-Ala 8.6 1.0 0.16 
L-Gln 1.6 1.3 0.13 
L-Glu 5.6 0 0.10 
L-Gly 2.0 1.5 0.10 
L-Leu 53.5 3.5 2.90 
L-Pro 9.5 3.5 0.12 
L-Val 111.0 1.2 9.40 
L-Am 4.8 0 0 
L-Asp 2.6 0 0 
L-He 46.8 0 0 
GPhe 77.6 0 0 
L-Ser 0.8 0 0 
L-Trp 0.9 0 0 
L-Thr 15.2 0 0 
The incubation mixture contained 100 11 of enzyme solution and 100 ~1 of a 
solution of buffer A containing 0.2 prnol ATP, 0.2 pmol ” PPi (approx. 0.1 r&i) 
and 0.2 pmol of one of the amino acids. The assay is described in [ 61. 
Table 2 
Aminoacyl tRNA activity with various amino acids 
pmoles attached to tRNA 
I4 C-labelled 
amino acid 
Sephadex G 200 
peak fraction 
Hydroxyapatite 
peak 1 
fractionation 
peak 2 
Aib 0 
L-Ala 28.8 
L-Gln 0.2 
L-Glu 0 
L-Gly 33.9 
L-Leu 47.5 
L-Pro 2.7 
L-val 81.0 
L-Ile 0 
L-Orn 0 
LPhe 252.0 
L-Ser 0 
LThr 28.0 
0 0 
0 0 
0 0 
0 0 
0 0 
8.1 19.0 
0.5 0 
19.0 0 
- - 
- 
- 
- 
- 
The assay is described under Materials and methods. 0.25 r&i of the labelled amino 
acids were added to the incubation mixture which contained 300 pg of E. co&tRNA. 
Incubation was carried out for 30 min at 37°C. 
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but not all of the ATP-32 PPi exchange activity 
can be attributed to aminoacyl tRNA ligase activity. 
Thus, the ligases activating Leu and Val are the 
most active. This may explain the high ATP-32 PPi 
exchange rates for these two amino acids compared 
with the others. The extremely high exchanges for 
Phe, Thr and Be are remarkable. For Phe and Thr, 
they are obviously caused by tRNA-ligases 
(compare tables 1 and 2). The Ile dependent 
ATP-32PPi exchange can not be explained by the 
action of an Be-tRNA-ligase. It may be attributed 
to a certain unspeciticity of the Val activating 
enzymes, the alamethicin synthetase and/or the 
Val-tRNA-ligase. The opposite case is well known; 
for example the Ile-tRNA-ligase from E. coli is 
capable of activating Val [9]. We could not detect 
any influence of phenylalaninol on the in vitro 
synthesis of alamethicin. 
The peak fraction of the gel filtration catalyzes 
the formation of alamethicin. Fig. 3 shows the 
incorporation of [14C]Aib into the peptide. The 
product synthesized in vitro possessed the same 
&values as the marker, alamethicin, when analyzed 
Front 
& 
I 
b) 
Fig.3. In vitro synthesis of alamethicin and separation by 
thin layer chromatography. Identification by autoradio- 
graphy with a Berthold scanner. The assay is described under 
Materials and methods. (a) Incorporation of [ “C]Aib; (b) 
marker [r4C]Aib; (c) marker [“C]alamethicin; (d) 
hydrolysate of the labelled alamethicin of (a). The t.Lc. 
plates were first developed with n-butanol - acetic acid - 
water (4: 1: l), then dried and developed in the same direction 
with pyridine - ethylacetate - acetic acid - water 
(20:60:6: 11). 
LO 50 
Fraction NO. 
I 
Fig.4. FractionatiorI of tlie.al&ethicin synthesizing system 
by chromatography on hydrbxyapatite. The Sephadex G 200 
peak fractions were pooled and applied to a hydroxyapatite 
column (1.5 X 15 cm). After washing with 100 ml of buffer 
A the column was eluted with 400 ml of a linear phosphate 
gradient, pH 7.0: contajning 10 mM Mg”, 0.5 mM EDTA, 
5 mM mercaptoethanol and 10% sucrose. (o -0) and 
(F-O) represent he ATPP3’PPi exchange activities of 
Aib and L-Val, respectively, (. . .) represents the optical 
density and (- - -) the phosp_hate gradient. 
by thin layer chromatography with the two 
solvents specified in ‘Materials and methods’ 
section. After hydrolysis of the labelled substance 
[14C] Aib was regained. In an earlier work we 
demonstrated the incorporation of other alameth- 
icin constituent amino acids [6]. 
The peak fraction of the gel filtration was 
fractionated into two peaks by chromatography 
on hydroxyapatite (fig.4). Peak 1 catalyzed the 
ATP-32PPi exchange for 7 of the 8 amino acids 
(all but Glu), and peak 2 activatedval and Leu 
(table 1). Peak 1 still contained some tRNA-ligase 
activity for Leu, Pro and Val. Peak 2 contained ligase 
activity for Leu, but notVa1 (table 2). Both peaks 
are required for alamethicin synthesis (table 3), 
i.e. a Val-activating subunit of the alamethicin synthe- 
tase has been split off under the conditions of 
hydroxyapatite chromatography. It is expected 
that the enzyme complex may be further fractio- 
nated by suitable methods. One has to consider 
that alamethicin is an octadecapeptide; the 
molecule is considerably larger than for example 
gramicidin S or tyrocidin, whose synthetases 
consist of two or three subunits, respectively 
[lO,ll]. 
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Table 3 
Dependence of alamethicin synthesis on two fractions 
Peak number Alamethicin 
synthesized (cpm) 
I 120 
II 50 
I + III 1450 
The incubation mixture contained either 400 /rl of peak I or 
II or 200 /II of each peak. The incubation conditions are 
described in Materials and methods. The in vitro synthesized 
alamethicin was separated by thin layer chromatography as 
described in the legend of fig.3, then extracted with ethanol. 
After evaporation of the alcohol radioactivity was counted 
under toluene scintillation liquid. 
The results published here and previously [6] 
indicate that there is an analogy between the first 
steps of the biosynthesis of alamethicin and the 
formation of gramidicin S and tyrocidine [ 12,131; 
the synthetase consists of several complementary 
subunits; the different amino acids are activated 
in the forms of aminoacyl adenylates and then 
they are bound to the synthesizing enzyme as 
thioesters. The polymerisation of the enzyme linked 
aminoacyl thioesters to form alamethicin requires 
further clarification. 
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